Reduction in MACbar of Sevoflurane by Dexmedetomidine in Children

NCT ID: NCT02261675

Last Updated: 2014-10-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

63 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-01-31

Study Completion Date

2014-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study was designed to define the interaction of intravenous infusion of dexmedetomidine, an a2-adrenergic agonist, and sevoflurane in children having surgery by using the minimum alveolar concentration which can block adrenergic and cardiovascular responses to incision(MACbar) of sevoflurane as the measure of anesthetic potency.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The investigators observed the effects of different doses of dexmedetomidine on the minimum alveolar concentration of sevoflurane to blockade adrenergic response to surgical incision in 50% of children (MACBAR). And to explore the safety of use of dexmedetomidine in pediatric patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Children

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

DOUBLE

Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

children undergoing selective lower abdominal surgery received saline before induction

Group Type NO_INTERVENTION

No interventions assigned to this group

D1 group

children undergoing selective lower abdominal surgery received a bolus dose of 0.5 µg/kg dexmedetomidine followed by a continuous infusion of 0.5 µg/kg /h before induction

Group Type EXPERIMENTAL

dexmedetomidine

Intervention Type DRUG

children received intravenous infusion with a bolus dose dexmedetomidine and followed by a continuous infusion before induction. use sevoflurane for induction and a steady-state end-tidal sevoflurane concentration was maintained for at least 15 min before skin incision.

D2 group

children undergoing selective lower abdominal surgery received a bolus dose of 1.0µg/kg dexmedetomidine followed by a continuous infusion of 1.0 µg/kg /h before induction

Group Type EXPERIMENTAL

dexmedetomidine

Intervention Type DRUG

children received intravenous infusion with a bolus dose dexmedetomidine and followed by a continuous infusion before induction. use sevoflurane for induction and a steady-state end-tidal sevoflurane concentration was maintained for at least 15 min before skin incision.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dexmedetomidine

children received intravenous infusion with a bolus dose dexmedetomidine and followed by a continuous infusion before induction. use sevoflurane for induction and a steady-state end-tidal sevoflurane concentration was maintained for at least 15 min before skin incision.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

precedex

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 2 to 6 yr
* American Society of anesthesiologists I or II
* scheduled to have general anesthesia and to have skin incisions on the abdomen

Exclusion Criteria

* anemia or abnormal preoperative electrolyte concentrations
* a history of cardiovascular or central nervous system diseases
* a history of pulmonary disease
* known hepatic or renal disease
* a body weight exceeding 50% of the upper limit of ideal body weight for height
* taking drugs with cardiovascular or central nervous system effects
* use of any experimental drug within the past 30 days
* allergy to any drug that may be administered during the study
* exposure to general anesthesia within the previous 7 days
* second- or third-degree atrioventricular block
* taking drugs preoperatively that would interfere with MAC determination(e.g.,opioids or sedatives)
Minimum Eligible Age

2 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cai Li

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Cai Li

Department of Anesthesiology, First Affiliated Hospital, Sun Yat-Sen University

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Xuan Ke Liu, Ph.d

Role: PRINCIPAL_INVESTIGATOR

Departmeng of Anesthesiology, The First Affiliated Hospital, Sun Yat-sen University

References

Explore related publications, articles, or registry entries linked to this study.

Albertin A, Casati A, Bergonzi P, Fano G, Torri G. Effects of two target-controlled concentrations (1 and 3 ng/ml) of remifentanil on MAC(BAR) of sevoflurane. Anesthesiology. 2004 Feb;100(2):255-9. doi: 10.1097/00000542-200402000-00012.

Reference Type RESULT
PMID: 14739797 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Macbar DEX

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dexmedetomidine and Ketamine in MRI
NCT02652507 COMPLETED PHASE1